BURNING ROCK BIOTECH LTD's ticker is BNR and the CUSIP is 12233L107.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $53,316 | -59.8% | 54,965 | -9.7% | 0.00% | – |
Q2 2023 | $132,753 | -22.4% | 60,896 | 0.0% | 0.00% | – |
Q1 2023 | $171,118 | +124803.6% | 60,896 | +0.2% | 0.00% | – |
Q4 2022 | $137 | -99.9% | 60,776 | -2.2% | 0.00% | – |
Q3 2022 | $149,000 | +86.2% | 62,159 | +124.7% | 0.00% | – |
Q2 2022 | $80,000 | – | 27,660 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,990,408 | $35,588,000 | 2.16% |
Prince Street Capital Management LLC | 184,000 | $3,289,000 | 2.05% |
SHEN NEIL NANPENG | 885 | $16,000 | 0.51% |
Orbimed Advisors | 1,856,201 | $33,189,000 | 0.36% |
HSG Holding Ltd | 212,121 | $3,793,000 | 0.34% |
AtonRa Partners | 40,701 | $728,000 | 0.24% |
Euro Pacific Asset Management, LLC | 29,305 | $524,000 | 0.14% |
Bellevue Group AG | 489,890 | $8,759,000 | 0.09% |
Baillie Gifford | 8,792,152 | $157,204,000 | 0.08% |
Hudson Bay Capital Management LP | 301,061 | $5,383,000 | 0.07% |